In the Health Policy Podcast episode featuring Wayne Winegarden from the Pacific Research Institute, the discussion centers on the 340B Drug Pricing Program. Winegarden critiques the program’s lack of transparency and its unintended consequences, which have led to large hospital systems profiting at the expense of smaller institutions and patients. He advocates for reforms, including improved transparency and a shift in funding models to better serve the intended vulnerable populations.
Listen to Wayne Winegarden on the Health Policy Podcast: The $100 Billion Loophole: Why 340B Reform is Essential
Related Posts
Approved in the Shadows: Connecticut’s Next Electric Rate Hike Is Already Locked In
Connecticut residents don’t need to wait for their next utility bill to know…
Minnesota’s Economic News — W/E 11/7/25
State and local taxes and spending Star Tribune: Ramstad: The next year is going…
Illinois loses 1,700 jobs in 2025 while nation adds 584,000
Illinois’ unemployment continued a long-term trend of remaining higher…
Government Shouldn’t Pick Winners and Losers—Especially on Your Utility Bill
Panasonic’s special rate deal shows how corporate favoritism quietly shifts…
Obamacare’s Policy Failures Come To Idaho
As the shutdown of the federal government extends beyond 30 days, the key…
Louisiana’s Tax Competitiveness Problem – Pelican Policy
The Tax Foundation’s recently released 2026 State Tax Competitiveness Index…
Fighting For Government Transparency at the Arizona Supreme Court
Transparency is the rule for public records in Arizona, and for good reason:…
Minnesota’s Economic News — W/E 1/30/26
Labor market Albert Lea Tribune: Minnesota jobs stable over the month and grew…
Week in Review: Union Members Only? Nope.
When people apply for government jobs, they should be judged on their merits and…
Illinois to eliminate poor attendance from school ratings
High chronic absenteeism will no longer hurt a school’s state…









